Počet záznamů: 1  

Structure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus

  1. 1.
    SYSNO ASEP0465631
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevStructure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus
    Tvůrce(i) Eyer, L. (CZ)
    Šmídková, Markéta (UOCHB-X) RID, ORCID
    Nencka, Radim (UOCHB-X) RID, ORCID
    Neča, J. (CZ)
    Kastl, T. (CZ)
    Palus, Martin (BC-A) RID, ORCID
    De Clercq, E. (BE)
    Růžek, Daniel (BC-A) RID, ORCID
    Zdroj.dok.Antiviral Research. - : Elsevier - ISSN 0166-3542
    Roč. 133, Sep (2016), s. 119-129
    Poč.str.11 s.
    Jazyk dok.eng - angličtina
    Země vyd.NL - Nizozemsko
    Klíč. slovastructure-activity relationship ; tick-borne encephalitis ; nucleoside inhibitor ; antiviral activity ; cytotoxicity
    Vědní obor RIVCC - Organická chemie
    Vědní obor RIV – spolupráceBiologické centrum (od r. 2006) - Mikrobiologie, virologie
    CEPNV16-34238A GA MZd - Ministerstvo zdravotnictví
    GA16-20054S GA ČR - Grantová agentura ČR
    Institucionální podporaUOCHB-X - RVO:61388963 ; BC-A - RVO:60077344
    UT WOS000384856200014
    EID SCOPUS84982836748
    DOI10.1016/j.antiviral.2016.07.018
    AnotaceTick-borne encephalitis (TBE) represents one of the most serious arboviral neuro-infections in Europe and northern Asia. As no specific antiviral therapy is available at present, there is an urgent need for efficient drugs to treat patients with TBE virus (TBEV) infection. Using two standardised in vitro assay systems, we evaluated a series of 29 nucleoside derivatives for their ability to inhibit TBEV replication in cell lines of neuronal as well as extraneural origin. The series of tested compounds included 2'-C- or 2'-O-methyl substituted nucleosides, 2'-C-fluoro-2'-C-methyl substituted nucleosides, 3'-O-methyl substituted nucleosides, 3'-deoxynucleosides, derivatives with 4'-C-azido substitution, heterobase modified nucleosides and neplanocins. Our data demonstrate a relatively stringent structure-activity relationship for modifications at the 2', 3', and 4' nucleoside positions. Whereas nucleoside derivatives with the methylation at the C2' position or azido modification at the C4'position exerted a strong TBEV inhibition activity (EC50 from 0.3 to 11.1 mu M) and low cytotoxicity in vitro, substitutions of the O2' and O3' positions led to a complete loss of anti-TBEV activity (EC50 > 50 mu M). Moreover, some structural modifications of the heterobase moiety resulted in a high increase of cytotoxicity in vitro. High antiviral activity and low cytotoxicity of C2' methylated or C4' azido substituted pharmacophores suggest that such compounds might represent promising candidates for further development of potential therapeutic agents in treating TBEV infection.
    PracovištěÚstav organické chemie a biochemie
    Kontaktasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
    Rok sběru2017
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.